|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
injection
|
|
gptkbp:alternativeTo
|
oral polio vaccine
|
|
gptkbp:approvedBy
|
gptkb:United_States
gptkb:World_Health_Organization
|
|
gptkbp:broadcastOn
|
multiple doses
|
|
gptkbp:composition
|
three serotypes of inactivated poliovirus
|
|
gptkbp:contains
|
inactivated poliovirus
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Jonas_Salk
|
|
gptkbp:form
|
injection
|
|
gptkbp:historicalSignificance
|
first effective polio vaccine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Salk polio vaccine
|
|
gptkbp:introduced
|
1955
|
|
gptkbp:namedAfter
|
gptkb:Jonas_Salk
|
|
gptkbp:prevention
|
poliomyelitis
|
|
gptkbp:publicHealthConcern
|
drastic reduction in polio cases worldwide
|
|
gptkbp:routeOfAdministration
|
intramuscular
subcutaneous
|
|
gptkbp:sideEffect
|
fever
mild redness
swelling at injection site
|
|
gptkbp:storage
|
refrigerated
|
|
gptkbp:type
|
inactivated polio vaccine
|
|
gptkbp:usedIn
|
global polio eradication campaigns
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Jonas_Salk
|
|
gptkbp:bfsLayer
|
5
|